Additionally, more than 150,000 other people reported experiencing adverse reactions from the drugs. Medication regarding tirzepatide, the active ingredient in Mounjaro, has had 106,189 adverse reactions and 120 reported deaths, all registered with the scheme. Semaglutide, the active ingredient in Wegovy, received reports of 48,089 reactions and 59 suspected related deaths. A total of 4,491 adverse reactions and 37 deaths were reported as being suspected to be linked to liraglutide, which is sold under the brand name Saxenda. The spokesperson said: "Reporting volumes can be influenced by increased use, greater awareness of a potential adverse reaction and other factors.